Drugmakers Pfizer and BioNTech have announced that their two-dose COVID-19 vaccine is safe and shows a robust antibody response in children ages five to 11. The vaccine makers conducted a study in which about 2,270 children in that age group were administered one-third of the adult dose, or 10 micrograms given three weeks apart. The companies said the shots were […]
